J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 85 (2004), 1717-1725; DOI 10.1099/vir.0.80044-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hertzig, T.
Right arrow Articles by Thiel, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hertzig, T.
Right arrow Articles by Thiel, V.
Agricola
Right arrow Articles by Hertzig, T.
Right arrow Articles by Thiel, V.
© 2004 Society for General Microbiology

Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA

Tobias Hertzig1,{dagger}, Elke Scandella2,{dagger}, Barbara Schelle1, John Ziebuhr1, Stuart G. Siddell3, Burkhard Ludewig2 and Volker Thiel2

1 Institute of Virology and Immunology, University of Würzburg, Würzburg, Germany
2 Research Department, Cantonal Hospital St Gallen, CH-9007 St Gallen, Switzerland
3 Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, Bristol, UK

Correspondence
Volker Thiel
volker.thiel{at}kssg.ch

A previously unknown coronavirus (CoV) is the aetiological agent causing severe acute respiratory syndrome (SARS), for which an effective antiviral treatment is urgently needed. To enable the rapid and biosafe identification of coronavirus replicase inhibitors, we have generated a non-cytopathic, selectable replicon RNA (based on human CoV 229E) that can be stably maintained in eukaryotic cells. Most importantly, the replicon RNA mediates reporter gene expression as a marker for coronavirus replication. We have used a replicon RNA-containing cell line to test the inhibitory effect of several compounds that are currently being assessed for SARS treatment. Amongst those, interferon-{alpha} displayed the strongest inhibitory activity. Our results demonstrate that coronavirus replicon cell lines provide a versatile and safe assay for the identification of coronavirus replicase inhibitors. Once this technology is adapted to SARS-CoV replicon RNAs, it will allow high throughput screening for SARS-CoV replicase inhibitors without the need to grow infectious SARS-CoV.

{dagger}T. H. and E. S. contributed equally to this work.

Published online ahead of print on 19 March 2004 as DOI 10.1099/vir.0.80044-0.




This article has been cited by other articles:


Home page
J. Virol.Home page
K. K. Eriksson, L. Cervantes-Barragan, B. Ludewig, and V. Thiel
Mouse Hepatitis Virus Liver Pathology Is Dependent on ADP-Ribose-1''-Phosphatase, a Viral Function Conserved in the Alpha-Like Supergroup
J. Virol., December 15, 2008; 82(24): 12325 - 12334.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Tekes, R. Hofmann-Lehmann, I. Stallkamp, V. Thiel, and H.-J. Thiel
Genome Organization and Reverse Genetic Analysis of a Type I Feline Coronavirus
J. Virol., February 15, 2008; 82(4): 1851 - 1859.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Zust, T. B. Miller, S. J. Goebel, V. Thiel, and P. S. Masters
Genetic Interactions between an Essential 3' cis-Acting RNA Pseudoknot, Replicase Gene Products, and the Extreme 3' End of the Mouse Coronavirus Genome
J. Virol., February 1, 2008; 82(3): 1214 - 1228.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Ziebuhr, B. Schelle, N. Karl, E. Minskaia, S. Bayer, S. G. Siddell, A. E. Gorbalenya, and V. Thiel
Human Coronavirus 229E Papain-Like Proteases Have Overlapping Specificities but Distinct Functions in Viral Replication
J. Virol., April 15, 2007; 81(8): 3922 - 3932.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. van den Born, C. C. Posthuma, K. Knoops, and E. J. Snijder
An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene
J. Gen. Virol., April 1, 2007; 88(4): 1196 - 1205.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Schutze, R. Ulferts, B. Schelle, S. Bayer, H. Granzow, B. Hoffmann, T. C. Mettenleiter, and J. Ziebuhr
Characterization of White Bream Virus Reveals a Novel Genetic Cluster of Nidoviruses
J. Virol., December 1, 2006; 80(23): 11598 - 11609.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. L. Graham, A. C. Sims, S. M. Brockway, R. S. Baric, and M. R. Denison
The nsp2 Replicase Proteins of Murine Hepatitis Virus and Severe Acute Respiratory Syndrome Coronavirus Are Dispensable for Viral Replication
J. Virol., November 1, 2005; 79(21): 13399 - 13411.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Putics, W. Filipowicz, J. Hall, A. E. Gorbalenya, and J. Ziebuhr
ADP-Ribose-1"-Monophosphatase: a Conserved Coronavirus Enzyme That Is Dispensable for Viral Replication in Tissue Culture
J. Virol., October 15, 2005; 79(20): 12721 - 12731.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Schelle, N. Karl, B. Ludewig, S. G. Siddell, and V. Thiel
Selective Replication of Coronavirus Genomes That Express Nucleocapsid Protein
J. Virol., June 1, 2005; 79(11): 6620 - 6630.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Chen, C. Gui, X. Luo, Q. Yang, S. Gunther, E. Scandella, C. Drosten, D. Bai, X. He, B. Ludewig, et al.
Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro
J. Virol., June 1, 2005; 79(11): 7095 - 7103.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. E. Coley, E. Lavi, S. G. Sawicki, L. Fu, B. Schelle, N. Karl, S. G. Siddell, and V. Thiel
Recombinant Mouse Hepatitis Virus Strain A59 from Cloned, Full-Length cDNA Replicates to High Titers In Vitro and Is Fully Pathogenic In Vivo
J. Virol., March 1, 2005; 79(5): 3097 - 3106.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2004 by the Society for General Microbiology.